Robert Malenka
Net worth: 10 M $ as of 31/05/2026
Net worth: 10 M $ as of 31/05/2026
Robert Malenka is the founder of MapLight Therapeutics, Inc., founded in 2018, where the title held is Director.
Current jobs include Deputy Director at Wu Tsai Neurosciences Institute and Member at the National Academy of Medicine (United States).
Former job includes Professor at the University of California from 1996 to 1999.
Education includes a doctorate from Stanford University School of Medicine, conferred in 1983.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2026 | 348,138 ( 0.82% ) | 10 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Founder | 23/06/2026 |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions